Fennec (FENC) Chief Strategy Officer Christiana Cioffi Receives 156-Share Award

What Happened Christiana Marie Cioffi, Chief Strategy Officer of Fennec Pharmaceuticals, had 156 shares released to her on June 30, 2026. The Form 4 reports an acquisition-type transaction (award/release) of 156 shares at an acquisition price of $0.00 (total per-filed value $0). The filing notes these shares were released from restrictions tied to an earlier award.

Key Details

• Transaction date: 2026-06-30; filing date: 2026-07-01 (timely).
• Reported acquisition: 156 shares at $0.00 per share (total $0 per the filing).
• Footnote: Shares were released from restriction from shares awarded on 2025-03-28.
• Shares owned after the transaction: not specified in this filing.

Context This was a release/vesting of previously awarded restricted shares, not an open-market purchase or sale. No cash was paid per the filing; such awards are part of executive compensation and do not, by themselves, signal a buy or sell decision by the insider.